Archive for September 2020
Prominent Australian and Russian Research Institutions Join Global Virus Network to Combat Viral Diseases
Center for Emerging Viruses, Inflammation and Therapeutics of the Menzies Health Institute Queensland (MHIQ) at Griffith University, Australia and the Chumakov Federal Scientific Center for Research and Development of Immune and Biological Products of the Russian Academy of Sciences Join GVN at Critical Time for Information Sharing Baltimore, Maryland, USA, September 8, 2020: The Global…
Read MoreGVN Center and Member Spotlight – David Ostrov
Members > Spotlights > David Ostrov GVN Center and Member Spotlight Dr. David Ostrov Associate Professor University of Florida, Department of Pathology, Immunology and Laboratory Medicine University of Florida College of Medicine Florida, United States What are you and your institution currently working on regarding COVID-19? We are studying genetic risk factors for SARS-CoV-2 infection,…
Read MoreGVN: Forefront Of Virology COVID-19 Webinar Series featuring Dr. Jonathan Sexton
WELCOME TO FEATURING DR. JONATHAN SEXTON – AUGUST 13, 2020 – “MORPHOLOGIC CELL PROFILING OF SARS-COV-2 INFECTED CELLS ENABLES DRUG REPURPOSING SCREENING” Jonathan Sexton Assistant Professor of Internal Medicine, Medical School Assistant Professor of Medicinal Chemistry, College of Pharmacy University of Michigan, USA Member, Global Virus Network Bio sketch Jonny Sexton is an assistant professor…
Read MoreWill Neutralizing and Therapeutic Antibodies Play a Role in the Treatment of COVID-19?
Interest has increasingly been focused on the potential of virus-neutralizing monoclonal antibodies (mAbs) to treat COVID-19 by passive immunization. These antibodies generally target the viral spike protein to prevent infection by blocking ACE2 receptor binding to its receptor binding domain (RBD). There are several issues, however, that need to be addressed to determine when and…
Read More